Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.47
Delayed Data
As of 3:59pm ET
 -0.08 / -3.14%
Today’s Change
1.93
Today|||52-Week Range
7.85
-22.16%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close2.55
Today’s open2.55
Day’s range2.40 - 2.55
Volume15,239
Average volume (3 months)77,092
Market cap$9.5M
Dividend yield--
Data as of 3:59pm ET, 03/28/2017

Growth & Valuation

Earnings growth (last year)-29.05%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.43

Competitors

 Today’s
change
Today’s
% change
ATOSAtossa Genetics Inc-0.08-6.84%
CYANCyanotech Corp+0.15+3.95%
BVXVBiondVax Pharmaceuti...+0.28+5.31%
ISRIsoRay Inc-0.02-2.62%
Data as of 4:01pm ET, 03/28/2017

Financials

Last reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$3.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts


Search for Jobs